Assay of active pharmaceutical ingredients in drug products based on relative response factors: Instrumentation insights and practical considerations

被引:0
|
作者
Liu, Lisa [1 ]
Mouallem, Ariel [1 ]
Xiao, Kang Ping [1 ]
Meisel, Jerry [1 ]
机构
[1] Bayer Consumer Hlth, Global R&D Prod Dev Ctr, Morristown, NJ 07960 USA
关键词
HPLC relative response factor (RRF); Potency assay; Slit width; Step width; Band width; 3D/2D data collection module; PERFORMANCE LIQUID-CHROMATOGRAPHY; REFERENCE-STANDARD; MULTI-COMPONENTS; ULTRAVIOLET; RUGGEDNESS; IMPURITIES;
D O I
暂无
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Relative Response Factors (RRFs) can be used for quantitation of one compound against another and it is widely used for Impurity analysis of pharmaceutical products; however, the application in potency assay is limited. Through an extensive study shown in this paper, it can be concluded that using the "RRF methodology" for potency assay is much more challenging compared to impurity analysis, due to the much tighter criteria required for potency analysis. The effects of instrument settings, which are rarely discussed or recognized in current HPLC analytical method development and quality release testing, are discussed. These factors impact the RRF just as much as other commonly recognized HPLC parameters. The effects of UV detector settings, i.e. Slit Width, Step Width, Band Width, and Data Collection Module, have been explored. This phenomenon has been demonstrated using three compounds to observe the impact of their quantitation due to the significant RRF variations. Finally, principles to reduce RRF variations have been discussed, and practical considerations of RRF application to method development and method transfer are provided. (C) 2020 The Authors. Published by Elsevier B.V.
引用
收藏
页数:13
相关论文
共 28 条
  • [11] Analytical Methodologies to Detect N-Nitrosamine Impurities in Active Pharmaceutical Ingredients, Drug Products and Other Matrices
    Manchuri, Krishna Moorthy
    Shaik, Mahammad Ali
    Gopireddy, Venkata Subba Reddy
    Sultan, Naziya
    Gogineni, Sreenivasarao
    CHEMICAL RESEARCH IN TOXICOLOGY, 2024, 37 (09) : 1456 - 1483
  • [12] Control and analysis of hydrazine, hydrazides and hydrazones-Genotoxic impurities in active pharmaceutical ingredients (APIs) and drug products
    Elder, D. P.
    Snodin, D.
    Teasdale, A.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2011, 54 (05) : 900 - 910
  • [13] A Green Approach for the Determination and Identification of Entacapone Polymorphs in an Active Pharmaceutical Ingredients and Drug Products by FTIR through Absorbance Mode
    Chavan, Rajendra S.
    Ullah, Qasim
    Yadav, Dharmveer Singh
    Pathan, Sabreena Yameen
    Arif, Pathan Mohd
    ANALYTICAL CHEMISTRY LETTERS, 2021, 11 (06) : 828 - 836
  • [14] Design of arginine-based therapeutic deep eutectic solvents as drug solubilization vehicles for active pharmaceutical ingredients
    Gutierrez, Alberto
    Aparicio, Santiago
    Atilhan, Mert
    PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2019, 21 (20) : 10621 - 10634
  • [15] Recent Trends in Product Development and Regulatory Issues on Impurities in Active Pharmaceutical Ingredient (API) and Drug Products. Part 2: Safety Considerations of Impurities in Pharmaceutical Products and Surveying the Impurity Landscape
    Karen M. Alsante
    Kim C. Huynh-Ba
    Steven W. Baertschi
    Robert A. Reed
    Margaret S. Landis
    Scott Furness
    Bernard Olsen
    Mark Mowery
    Karen Russo
    Robert Iser
    Gregory A. Stephenson
    Patrick Jansen
    AAPS PharmSciTech, 2014, 15 : 237 - 251
  • [16] Recent Trends in Product Development and Regulatory Issues on Impurities in Active Pharmaceutical Ingredient (API) and Drug Products. Part 2: Safety Considerations of Impurities in Pharmaceutical Products and Surveying the Impurity Landscape
    Alsante, Karen M.
    Huynh-Ba, Kim C.
    Baertschi, Steven W.
    Reed, Robert A.
    Landis, Margaret S.
    Furness, Scott
    Olsen, Bernard
    Mowery, Mark
    Russo, Karen
    Iser, Robert
    Stephenson, Gregory A.
    Jansen, Patrick
    AAPS PHARMSCITECH, 2014, 15 (01): : 237 - 251
  • [17] Revisiting fish toxicity of active pharmaceutical ingredients: Mechanistic insights from integrated ligand-/structure-based assessments on acetylcholinesterase
    Minovski, Nikola
    Sacan, Melek Turker
    Eminoglu, Elif Merve
    Erdem, Safiye Sag
    Novic, Marjana
    ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY, 2019, 170 : 548 - 558
  • [18] Use of Enzymes in the Manufacture of Active Pharmaceutical Ingredients-A Science and Safety-Based Approach To Ensure Patient Safety and Drug Quality
    Wells, Andrew S.
    Finch, Gregory L.
    Michels, Peter C.
    Wong, John W.
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2012, 16 (12) : 1986 - 1993
  • [19] Analysis of unknown (unlabeled/mislabeled) drug products for active pharmaceutical ingredients and related substances by an international mail facility satellite laboratory equipped with rapid screening devices
    Lanzarotta, Adam
    Kern, Sara
    Batson, Jacinta
    Collins, Melissa
    Patel, Anvi
    Altaf, Muhammad
    Arrecis, Julio
    Boyd, Brian
    Illan, Fernando Gonzalez
    Griffin, Kelsey M.
    Howe, Gregory
    Hudson-Davis, Morgan
    Kimani, Martin
    Lagarde, Donna
    Laguerre, David
    Loh, Mark
    Lorenz, Lisa
    Morales-Garcia, Flavia
    Sterling, Megan E.
    Reimer, Allison M.
    Thatcher, Michael
    Wetherby, Anthony E.
    JOURNAL OF FORENSIC SCIENCES, 2024, 69 (04) : 1212 - 1221
  • [20] The Use of Systemically Absorbed Drugs to Explore An In Vitro Bioequivalence Approach For Comparing Non-Systemically Absorbed Active Pharmaceutical Ingredients in Drug Products For Use in Dogs
    Martinez, Marilyn N.
    Fahmy, Raafat
    Li, Linge
    Herath, Kithsiri
    Hollenbeck, R. Gary
    Ibrahim, Ahmed
    Hoag, Stephen W.
    Longstaff, David
    Gao, Shasha
    Myers, Michael J.
    PHARMACEUTICAL RESEARCH, 2024, 41 (09) : 1797 - 1809